Stereotactic body radiation therapy for post-pulmonary lobectomy isolated lung metastasis of thoracic tumor: survival and side effects

Table 1 Treatment in present study (n = 23)

Stereotactic body radiation therapy
*Irradiation dose delivered*
12 Gy × 4 fractions three times per week	11 (47.8%)
10 Gy × 5 fractions three times per week	9 (39.1%)
8 Gy × 7 fractions three times per week	3 (13.0%)
*Active breathing control*	23 (100%)
*Cone-beam CT guiding*	23 (100%)
*PTV volume (cm* ³ )
Median	48.4
Range	26.0-110.2
*Lung volume (cm* ³ )
Total lung (median)	2301.4
(range)	1983.4-2950.5
Contralateral lung (median)	1373.4
(range)	1255.8-1712.3
Ipsilateral lung (median)	942.2
(range)	786.8-1233.4
Systematic treatment
*Chemotherapy*
Concurrent chemotherapy	1 (4.3%)
Sequential chemotherapy	14 (60.9%)
*Tyrosine kinase inhibitor* ^a	3 (13.0%)
*None*	5 (21.7%)

ISSN: 1471-2407